Network pharmacology revealed 422 shared targets between HL4 and MIRI, with a PPI network highlighting hub genes including TP53, a pivotal tumor suppressor regulating cell cycle and apoptosis, crucial for cardiomyocyte survival under stress (Zhao et al., 2023; Tang et al., 2025). The gene discussed is TP53; the disease is neoplasm.